Global Automatic Molecular Imaging System Market Strategic Research Report

Scope of the Report

The global Automatic Molecular Imaging System market size is predicted to grow from US$ 1,388 million in 2025 to US$ 3,291 million in 2032; it is expected to grow at a CAGR of 13.4% from 2026 to 2032.

An Automatic Molecular Imaging System is an advanced platform for real-time visualization and quantification of biological processes using fluorescence, bioluminescence, PET/SPECT tracers, or multimodal imaging. It plays a critical role in oncology research, gene and cell therapy development, pharmacokinetic profiling and biodistribution studies. In 2024, the global average system price is approximately US$310,000, with around 4,050 units installed. Together with consumables such as fluorescent probes, radiotracers and software licenses. Gross margins typically range from 45%–65%, depending on system modality, detector sensitivity, automation features and AI-enabled analysis. The supply chain includes optical sensors, radiation detectors, precision mechanics and imaging software; midstream manufacturers integrate hardware and automated workflows; downstream users include biopharma companies, research institutes, CROs and CGT developers.

The automatic molecular imaging system market has been experiencing significant growth in recent years and is expected to continue its upward trajectory in the coming years. Several key trends are shaping the industry and driving the demand for automatic molecular imaging systems.the increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, is driving the growth of the automatic molecular imaging system market. Automatic molecular imaging systems play a crucial role in the early detection, diagnosis, and monitoring of these diseases. These systems utilize advanced imaging techniques, such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), and magnetic resonance imaging (MRI), to visualize and analyze molecular and cellular processes in the body. As the incidence of chronic diseases continues to rise globally, there is a growing need for accurate and efficient diagnostic tools, leading to increased demand for automatic molecular imaging systems.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Automatic Molecular Imaging System market?

What factors are driving Automatic Molecular Imaging System market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Automatic Molecular Imaging System market opportunities vary by end market size?

How does Automatic Molecular Imaging System break out by Type, by Application?

This report presents a comprehensive overview of the global Automatic Molecular Imaging System market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Desktop Type
• Floor Type

Segment by Imaging Modality

• Fluorescence Imaging
• Bioluminescence Imaging
• PET Molecular Imaging
• SPECT Imaging
• CT/MRI Multimodal Fusion
• Optical + Ultrasound Hybrid

Segment by Automation Level

• Manual Workflow System
• Semi-automatic System
• Fully Automated Imaging System

Segment by Application

• Medical
• Research

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Automatic Molecular Imaging System market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Medical, Research evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact